do-me/EUR-LEX huggingface dataset:
Authorisation for State aid pursuant to Articles 107 and 108 of the Treaty on the Functioning of the European Union – Cases where the Commission raises no objections – SA.114064
Date: 2024-06-24
Institutions: Directorate-General for Competition, European Commission
Subjects: Bulgaria, State aid, animal production, control of State aid, crop production, hunting, service








C_202403956EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2024/3956


24.6.2024






Authorisation for State aid pursuant to Articles 107 and 108 of the Treaty on the Functioning of the European Union
Cases where the Commission raises no objections
SA.114064
(C/2024/3956)








Date of adoption of the decision


23.5.2024




Aid number


SA.114064




Member State


Bulgaria




Region


 




Title (title and/or name of the beneficiary)


TCTF: ‘Помощ в подкрепа на ликвидността на земеделски стопани, производители на зърнени и маслодайни култури, за преодоляване на негативното икономическо въздействие на руската агресия срещу Украйна’ (First amendment to SA.112832 (2024/N))




Legal basis


Чл. 11, ал. 2, т. 1 и чл. 12, ал. 1, т. 2 от Закона за подпомагане на земеделските производители.




Type of measure


Scheme


 




Objective


Remedy for a serious disturbance in the economy




Form of aid


Direct grant




Budget


Overall budget: 45 000 000  BGN




Intensity


 




Duration


Until 30.6.2024




Economic sectors


Crop and animal production, hunting and related service activities




Name and address of the granting authority







Държавен фонд ‘Земеделие’




гр. София, бул. ‘Цар Борис III’ № 136








Other information


 




The authentic text(s) of the decision, from which all confidential information has been removed, can be found at:

https://competition-cases.ec.europa.eu/search?caseInstrument=SA



ELI: http://data.europa.eu/eli/C/2024/3956/oj
ISSN 1977-091X (electronic edition)
Euro exchange rates – 21 June 2024
Date: 2024-06-24
Institutions: European Commission
Subjects: euro, exchange rate, money








C_202403705EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2024/3705


24.6.2024






Euro exchange rates (1)


            21 June 2024
         
(C/2024/3705)


1 euro =











 


Currency


Exchange rate




USD


US dollar


1,0688 




JPY


Japanese yen


169,82 




DKK


Danish krone


7,4580 




GBP


Pound sterling


0,84531 




SEK


Swedish krona


11,2445 




CHF


Swiss franc


0,9537 




ISK


Iceland króna


149,10 




NOK


Norwegian krone


11,2685 




BGN


Bulgarian lev


1,9558 




CZK


Czech koruna


24,949 




HUF


Hungarian forint


396,93 




PLN


Polish zloty


4,3220 




RON


Romanian leu


4,9773 




TRY


Turkish lira


35,1129 




AUD


Australian dollar


1,6031 




CAD


Canadian dollar


1,4632 




HKD


Hong Kong dollar


8,3401 




NZD


New Zealand dollar


1,7427 




SGD


Singapore dollar


1,4468 




KRW


South Korean won


1 484,58 




ZAR


South African rand


19,1241 




CNY


Chinese yuan renminbi


7,7602 




IDR


Indonesian rupiah


17 597,85 




MYR


Malaysian ringgit


5,0373 




PHP


Philippine peso


62,920 




RUB


Russian rouble


 




THB


Thai baht


39,150 




BRL


Brazilian real


5,8107 




MXN


Mexican peso


19,5271 




INR


Indian rupee


89,3150 






(1)  
            Source: reference exchange rate published by the ECB.


ELI: http://data.europa.eu/eli/C/2024/3705/oj
ISSN 1977-091X (electronic edition)
Summary of European Commission Decisions on authorisations for the placing on the market for the use and/or for use of substances listed in Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) (Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006)
Date: 2024-06-24
Institutions: Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs, European Commission
Subjects: chemical compound, chemical product, genetics, health control, health risk, market approval, marketing standard, therapeutics








C_202403820EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2024/3820


24.6.2024






Summary of European Commission Decisions on authorisations for the placing on the market for the use and/or for use of substances listed in Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH)


(Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006
                (1)
)


(Text with EEA relevance)
(C/2024/3820)


Decision granting an authorisation













Reference of the decision (2)



Date of decision


Substance name


Holder of the authorisation


Authorisation number


Authorised use


Date of expiry of review period


Reasons for the decision




C(2024) 3904


17 June 2024


4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated (EC No 799-991-7; CAS No 9036-19-5)


MeiraGTx Ireland Designated Activity Company, Block K, Airport Avenue, Shannon Free Zone, V14 PT88, Shannon, Ireland


REACH/24/20/0


Manufacturing aid in the production of gene therapies


11 November 2034


In accordance with Article 60(4) of Regulation (EC) No 1907/2006, the socio-economic benefits outweigh the risk to human health and the environment from the use of the substance and there are no suitable alternative substances or technologies.






(1)  
            OJ L 396, 30.12.2006, p. 1.

(2)  The decision is available on the European Commission website at: Authorisation (europa.eu)



ELI: http://data.europa.eu/eli/C/2024/3820/oj
ISSN 1977-091X (electronic edition)
Commission Delegated Regulation (EU) 2024/2765 of 24 June 2024 correcting the Polish language version of Commission Delegated Regulation (EU) 2015/35 supplementing Directive 2009/138/EC of the European Parliament and of the Council on the taking-up and pursuit of the business of Insurance and Reinsurance (Solvency II)
Date: 2024-06-24
Institutions: Directorate-General for Translation, European Commission
Subjects: credit control, financial control, financial solvency, insurance company, market supervision, reinsurance








L_202402765EN.000101.fmx.xml












Official Journal of the European Union


EN
L series













2024/2765


25.10.2024







            COMMISSION DELEGATED REGULATION (EU) 2024/2765
of 24 June 2024
         
correcting the Polish language version of Commission Delegated Regulation (EU) 2015/35 supplementing Directive 2009/138/EC of the European Parliament and of the Council on the taking-up and pursuit of the business of Insurance and Reinsurance (Solvency II)
(Text with EEA relevance)


THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,


Having regard to Directive 2009/138/EC of the European Parliament and of the Council of 25 November 2009 on the taking-up and pursuit of the business of Insurance and Reinsurance (Solvency II) (1), and in particular Article 99, point (a), and Article 111(1), points (b), (c), (f) and (j) thereof,

Whereas:







(1)


The Polish language version of Commission Delegated Regulation (EU) 2015/35 (2) contains an error in Article 82(1), point (b), as regards the eligible amount of Tier 3 items, as well as errors in Article 134(4), Article 209(3) and Article 218(2), point (b), as regards the applicable periods of 12 months. The errors affect the substance of those provisions.












(2)


The Polish language version of Delegated Regulation (EU) 2015/35 should therefore be corrected accordingly. The other language versions are not affected,





HAS ADOPTED THIS REGULATION:



Article 1

(Does not concern the English language.)



Article 2
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.




This Regulation shall be binding in its entirety and directly applicable in all Member States.
Done at Brussels, 24 June 2024.


For the Commission


The President

Ursula VON DER LEYEN
            





(1)  
            OJ L 335, 17.12.2009, p. 1, ELI: http://data.europa.eu/eli/dir/2009/138/oj.

(2)  Commission Delegated Regulation (EU) 2015/35 of 10 October 2014 supplementing Directive 2009/138/EC of the European Parliament and of the Council on the taking-up and pursuit of the business of Insurance and Reinsurance (Solvency II) (OJ L 12, 17.1.2015, p. 1, ELI: http://data.europa.eu/eli/reg_del/2015/35/oj).


ELI: http://data.europa.eu/eli/reg_del/2024/2765/oj
ISSN 1977-0677 (electronic edition)
Non-opposition to a notified concentration (Case M.11512 – OTPP / NORDIC CAPITAL / ADVANZ PHARMA)
Date: 2024-06-24
Institutions: Directorate-General for Competition, European Commission
Subjects: economic concentration, investment company, merger control, pension scheme, pharmaceutical product, supply, teacher








C_202404278EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2024/4278


3.7.2024






Non-opposition to a notified concentration
(Case M.11512 – OTPP / NORDIC CAPITAL / ADVANZ PHARMA)
(Text with EEA relevance)
(C/2024/4278)

On 24 June 2024, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:






—


in the merger section of the ‘Competition policy’ website of the Commission (https://competition-cases.ec.europa.eu/search). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,










—


in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32024M11512. EUR-Lex is the online point of access to European Union law.






(1)  
            OJ L 24, 29.1.2004, p. 1.


ELI: http://data.europa.eu/eli/C/2024/4278/oj
ISSN 1977-091X (electronic edition)
Case C-445/24, (W)onderweg: Request for a preliminary ruling from the Hof van Cassatie (Belgium) lodged on 24 June 2024 – MS Amlin Insurance SE v (W)onderweg VZW
Date: 2024-06-24
Institutions: Court of Justice
Subjects: non-profit organisation, package travel, traveller








C_202406072EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2024/6072


21.10.2024






Request for a preliminary ruling from the Hof van Cassatie (Belgium) lodged on 24 June 2024 – MS Amlin Insurance SE v (W)onderweg VZW


(Case C-445/24, (W)onderweg)

(C/2024/6072)
Language of the case: Dutch

Referring court

Hof van Cassatie

Parties to the main proceedings


Appellant in cassation: MS Amlin Insurance SE

Respondent in cassation: (W)onderweg VZW

Question referred

Is the concept of a ‘traveller’ in Article 3(6) of Directive (EU) 2015/2302 (1) of the European Parliament and of the Council of 25 November 2015 on package travel and linked travel arrangements, amending Regulation (EC) No 2006/2004 and Directive 2011/83/EU of the European Parliament and of the Council and repealing Council Directive 90/314/EEC be interpreted as meaning that it also includes a legal person, such as a non-profit association which occasionally buys package travel from a trader for its members?


(1)  Directive (EU) 2015/2302 of the European Parliament and of the Council of 25 November 2015 on package travel and linked travel arrangements, amending Regulation (EC) No 2006/2004 and Directive 2011/83/EU of the European Parliament and of the Council and repealing Council Directive 90/314/EEC (OJ 2015 L 326, p. 1).


ELI: http://data.europa.eu/eli/C/2024/6072/oj
ISSN 1977-091X (electronic edition)
Prior notification of a concentration (Case M.11574 - L CATTERTON / KIKO) – Candidate case for simplified procedure
Date: 2024-06-24
Institutions: Directorate-General for Competition, European Commission
Subjects: cosmetics industry, economic concentration, investment company, merger control








C_202403985EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2024/3985


24.6.2024






Prior notification of a concentration
(Case M.11574 - L CATTERTON / KIKO)
Candidate case for simplified procedure
(Text with EEA relevance)
(C/2024/3985)


1.   
On 13 June 2024, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1).
This notification concerns the following undertakings:






—


L Catterton Management Limited (‘L Catterton’, United States),










—


KIKO S.p.A. (‘KIKO’, Italy).




L Catterton will indirectly acquire within the meaning of Article 3(1)(b) of the Merger Regulation sole control of the whole of KIKO.
The concentration is accomplished by way of purchase of shares.


2.   
The business activities of the undertakings concerned are the following:






—


L Catterton is a consumer-focused investment firm, whose portfolio companies operate in the retail and restaurant business, the food and beverage business, and other consumer service and consumer product businesses including the production and sale of clothing and fashion accessories, cosmetics and fragrance products across the globe but primarily in the United States,










—


KIKO offers a wide range of mass cosmetics (including make-up and make-up-related accessories), skincare, body care, sun care and more recently haircare products and fragrances across the globe but primarily in the EU, specifically in Italy.






3.   
On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.
Pursuant to the Commission Notice on a simplified treatment for certain concentrations under Council Regulation (EC) No 139/2004 on the control of concentrations between undertakings (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.


4.   
The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:
M.11574 - L CATTERTON / KIKO
Observations can be sent to the Commission by email or by post. Please use the contact details below:
Email: COMP-MERGER-REGISTRY@ec.europa.eu

Postal address:





European Commission




Directorate-General for Competition




Merger Registry




1049 Bruxelles/Brussel




BELGIQUE/BELGIË







(1)  
            OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2)  
            OJ C 160, 5.5.2023, p. 1.


ELI: http://data.europa.eu/eli/C/2024/3985/oj
ISSN 1977-091X (electronic edition)
Case T-312/24: Action brought on 24 June 2024 – Real Pharm Group v EUIPO – real (REAL PHARM)
Date: 2024-06-24
Institutions: General Court
Subjects: EU trade mark, baby food, dietary product, food supplement, registered trade mark, retail trade, trade-mark law, vitamin, wholesale trade








C_202404862EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2024/4862


12.8.2024






Action brought on 24 June 2024 – Real Pharm Group v EUIPO – real (REAL PHARM)


(Case T-312/24)

(C/2024/4862)
Language in which the application was lodged: English

Parties


Applicant: Real Pharm Group sp. z o.o. (Czaplinek, Poland) (represented by: A.-M. Sobczak, lawyer)

Defendant: European Union Intellectual Property Office

Other party to the proceedings before the Board of Appeal: real GmbH (Mönchengladbach, Germany)

Details of the proceedings before EUIPO


Applicant of the trade mark at issue: Applicant before the General Court

Trade mark at issue: Application for European Union figurative mark REAL PHARM – Application for registration No 18 608 282
         

Procedure before EUIPO: Opposition proceedings

Contested decision: Decision of the First Board of Appeal of EUIPO of 24 April 2024 in Case R 1376/2023-1

Form of order sought

The applicant claims that the Court should:






—


annul the contested decision;










—


alter the contested decision and declare the appeal justified and the opposition unfounded in its entirety;










—


order the reimbursement of its costs according to prescribed standards.





Pleas in law







—


Infringement of Article 8(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council;










—


Infringement of Article 18 of Regulation (EU) 2017/1001 of the European Parliament and of the Council.






ELI: http://data.europa.eu/eli/C/2024/4862/oj
ISSN 1977-091X (electronic edition)
Case T-314/24: Action brought on 24 June 2024 – Seon Technologies v EUIPO (FRAUD FIGHTERS)
Date: 2024-06-24
Institutions: General Court
Subjects: EU trade mark, artificial intelligence, consultancy, data protection, information security, information technology, provision of services, registered trade mark, software, trade-mark law








C_202404863EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2024/4863


12.8.2024






Action brought on 24 June 2024 – Seon Technologies v EUIPO (FRAUD FIGHTERS)


(Case T-314/24)

(C/2024/4863)
Language of the case: English

Parties


Applicant: Seon Technologies Kft. (Budapest, Hungary) (represented by: M. Brandusa and G. Baksay-Nagy, lawyers)

Defendant: European Union Intellectual Property Office

Details of the proceedings before EUIPO


Trade mark at issue: International registration designating the European Union in respect of the mark FRAUD FIGHTERS – Application for registration No 1 727 782
         

Contested decision: Decision of the First Board of Appeal of EUIPO of 25 April 2024 in Case R 2209/2023-1

Form of order sought

The applicant claims that the Court should:






—


annul the contested decision;










—


declare that Article 7(1)(b) of Regulation (EU) No 2017/1001 of the European Parliament and of the Council does not preclude registration of the trade mark applied for in respect of the goods and services at issue;










—


declare that Article 7(1)(c) of Regulation (EU) No 2017/1001 of the European Parliament and of the Council does not preclude registration of the trade mark applied for in respect of the goods and services at issue;










—


order EUIPO to pay the costs.





Pleas in law







—


Infringement of Articles 7(1)(c) and 7(2) of Regulation (EU) 2017/1001 of the European Parliament and of the Council;










—


Infringement of Articles 7(1)(b) and 7(2) of Regulation (EU) 2017/1001 of the European Parliament and of the Council;










—


Breach of the principles of equal treatment and sound administration;










—


Infringement of Article 94(1) of Regulation (EU) 2017/1001 of the European Parliament and of the Council.






ELI: http://data.europa.eu/eli/C/2024/4863/oj
ISSN 1977-091X (electronic edition)
Council Decision (CFSP) 2024/1770 of 24 June 2024 concerning restrictive measures in view of Russia’s actions destabilising the situation in Ukraine
Date: 2024-06-24
Institutions: Council of the European Union
Subjects: EU restrictive measure, Russia, Russo-Ukrainian issue, Ukraine, economic sanctions, international sanctions, legal person, mass media, territorial dispute, trade restriction








L_202401770EN.000101.fmx.xml












Official Journal of the European Union


EN
L series













2024/1770


24.6.2024







            COUNCIL DECISION (CFSP) 2024/1770
         
of 24 June 2024
         
concerning restrictive measures in view of Russia’s actions destabilising the situation in Ukraine


THE COUNCIL OF THE EUROPEAN UNION,

Having regard to the Treaty on European Union, and in particular Article 29 thereof,


Having regard to the proposal from the High Representative of the Union for Foreign Affairs and Security Policy,

Whereas:







(1)


On 31 July 2014, the Council adopted Decision 2014/512/CFSP (1).












(2)


On 17 May 2024, the Council adopted Decision (CFSP) 2024/1429 (2), which amended Decision 2014/512/CFSP and introduced further restrictive measures to suspend the broadcasting activities in the Union, or directed at the Union, of certain media outlets referred to in the Annex to Decision (CFSP) 2024/1429. Pursuant to Article 1 of that Decision, the applicability of such measures in respect of one or several of those media outlets is subject to a further decision by the Council.












(3)


Having examined the respective cases, the Council has concluded that the restrictive measures referred to in Article 4g of Decision 2014/512/CFSP should apply as of 25 June 2024 in respect of all entities referred to in the Annex to Decision (CFSP) 2024/1429,





HAS ADOPTED THIS DECISION:



Article 1
The restrictive measures referred to in Article 4g of Decision 2014/512/CFSP shall apply as of 25 June 2024 in respect of all entities referred to in the Annex to Decision (CFSP) 2024/1429.


Article 2
This Decision shall enter into force on the day following that of its publication in the Official Journal of the European Union.




Done at Luxembourg, 24 June 2024.


For the Council


The President

J. BORRELL FONTELLES
            





(1)  Council Decision 2014/512/CFSP of 31 July 2014 concerning restrictive measures in view of Russia’s actions destabilising the situation in Ukraine (OJ L 229, 31.7.2014, p. 13).

(2)  Council Decision (CFSP) 2024/1429 of 17 May 2024 amending Decision 2014/512/CFSP concerning restrictive measures in view of Russia’s actions destabilising the situation in Ukraine (OJ L, 2024/1429, 17.05.2024, ELI: http://data.europa.eu/eli/dec/2024/1429/oj).


ELI: http://data.europa.eu/eli/dec/2024/1770/oj
ISSN 1977-0677 (electronic edition)